MIRA Pharmaceuticals (NASDAQ:MIRA) | WebDisclosure

Basculer en Français

10135	Companies
207943	Keywords
138035	Articles
110196	Press releases

Home
Companies
MIRA Pharmaceuticals

PRESS RELEASE

published on 07/22/2024 at 14:00, 1 year 8 months ago

MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance
MIRA Pharmaceuticals reveals new promising preclinical data for Ketamir-2, a novel oral ketamine analog, indicating potential advantages for treating neurological and neuropsychiatric disorders

Preclinical Study Neurological Disorders MIRA Pharmaceuticals Neuropsychiatric Disorders Ketamir-2
BRIEF

published on 07/15/2024 at 13:05, 1 year 8 months ago

Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC

Pharmaceuticals Preclinical Studies MIRA-55 Anxiety Treatment THC Comparison
BRIEF

published on 07/15/2024 at 13:05, 1 year 8 months ago

Mira Pharmaceuticals annonce des résultats prometteurs pour MIRA-55 dans plusieurs tests précliniques par rapport au THC

Médicaments Etudes Précliniques MIRA-55 Traitement De L'anxiété Comparaison Du THC
PRESS RELEASE

published on 07/15/2024 at 13:00, 1 year 8 months ago

Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC
MIRA Pharmaceuticals, Inc. confirms promising findings on new oral pharmaceutical marijuana analog, MIRA-55, as a potential treatment for neurological and neuropsychiatric disorders. Comparison to THC shows enhanced efficacy and consistent anxiolytic effects

Neurological Disorders Preclinical Studies MIRA-55 MIRA Pharmaceuticals Neuropsychiatric Disorders

Accesswire

Published on 04/01/2026 at 04:40, 1 hour 27 minutes ago

Closing Of Non-Brokered Private Placement
Published on 04/01/2026 at 04:06, 2 hours 1 minute ago

Jaguar Mining Reports Financial Results for the Fourth Quarter and Full Year 2025
Published on 04/01/2026 at 03:57, 2 hours 10 minutes ago

NXT Energy Solutions Announces 2025 Year-End Results
Published on 04/01/2026 at 03:10, 2 hours 57 minutes ago

Jaguar Mining Reports Updated Significant 49% Increase in Mineral Reserves at Pilar Mine, Reinforcing Long Term Growth Strategy
Published on 04/01/2026 at 01:40, 4 hours 27 minutes ago

Thunder Rock Capital Serves as Exclusive Financial Advisor in Crown Reserve Acquisition Corp. I's Proposed $1.0 Billion Business Combination with Carvix, Inc.

View all ACCESSWIRE

EQS Group

Published on 04/01/2026 at 00:15, 5 hours 52 minutes ago

Mesabi Metallics Secures $520 Million from Breakwall Capital - Advances towards Q3 2026 start of New American Iron Ore Mine
Published on 03/31/2026 at 23:05, 7 hours 2 minutes ago

DeFi Technologies Announces Preliminary Unaudited Full Year 2025 Financial Results with Record Revenue of $99.1 Million and Record Net Income of $62.7 Million; Appoints New Independent Chair of the Audit Committee
Published on 03/31/2026 at 22:15, 7 hours 52 minutes ago

Amrize Appoints Baris Oran as Chief Financial Officer
Published on 03/31/2026 at 20:30, 9 hours 37 minutes ago

Mutares has sold Kalzip to Tremco CPG
Published on 03/31/2026 at 20:30, 9 hours 37 minutes ago

Press release: General Meeting approves all proposals – Markus Schürch elected new Chairman of the Board of Directors

Les Echos

Published on 03/31/2026 at 20:08, 9 hours 59 minutes ago

SMTPC - Communiqué sur les résultats annuels 2025
Published on 03/31/2026 at 19:05, 11 hours 1 minute ago

SFPI GROUP: implementation of a new liquidity contract
Published on 03/31/2026 at 19:05, 11 hours 1 minute ago

Groupe SFPI : mise en oeuvre d'un nouveau contrat de liquidité
Published on 03/31/2026 at 19:00, 11 hours 7 minutes ago

COGRA : Transfert du contrat de liquidité chez TSAF
Published on 03/31/2026 at 18:34, 11 hours 33 minutes ago

Damartex / Transfert du contrat de liquidité auprès du Crédit Industriel et Commercial

View all LES ECHOS COMFI WIRE